MTOR and neoplasm with perivascular epithelioid cell differentiation: Four out of five cases of unresectable PEComa due to tumor size or metastatic disease proceeded fatal, one case of malignant epitheloid angiomyolipoma showed a good response to systemic therapy with an mTOR-inhibitor for 7 months of follow-up [9–13].